MedPath
FDA Approval

Teriparatide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Prasco Laboratories
DUNS: 065969375
Effective Date
December 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Teriparatide(250 ug in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Eli Lilly and Company

006421325

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Teriparatide

Product Details

NDC Product Code
66993-495
Application Number
NDA021318
Marketing Category
NDA authorized generic (C73605)
Route of Administration
SUBCUTANEOUS
Effective Date
November 17, 2023
sodium acetate anhydrousInactive
Code: NVG71ZZ7P0Class: IACTQuantity: 0.1 mg in 1 mL
acetic acidInactive
Code: Q40Q9N063PClass: IACTQuantity: 0.41 mg in 1 mL
Code: 10T9CSU89IClass: ACTIBQuantity: 250 ug in 1 mL
mannitolInactive
Code: 3OWL53L36AClass: IACTQuantity: 45.4 mg in 1 mL
MetacresolInactive
Code: GGO4Y809LOClass: IACTQuantity: 3.0 mg in 1 mL
sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
hydrochloric acidInactive
Code: QTT17582CBClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath